Episode 10: Ingrid Young talks about TasP and PreP

In Episode 10, Dr Ingrid Young, a Research Fellow at the MRC/CSO Social and Public Health Sciences Unit, University of Glasgow, talks to Karen about treatment as prevention (TasP) and pre-exposure prophylaxis (PreP), in relation to HIV prevention.  She conveys findings from qualitative work within her discussion.

Podcast: Play in new window | Download

Subscribe: iTunes | Android | RSS

You can subscribe to the podcast on iTunes

Links to articles:
Barriers to uptake and use of pre-exposure prophylaxis (PrEP) among communities most affected by HIV in the UK: findings from a qualitative study in Scotland
BMJ Open

How Acceptable are Antiretrovirals for the Prevention of Sexually Transmitted HIV?: A Review of Research on the Acceptability of Oral Pre-exposure Prophylaxis and Treatment as Prevention
AIDS and Behavior

Awareness and Willingness to Use HIV Pre-Exposure Prophylaxis amongst Gay and Bisexual Men in Scotland: Implications for Biomedical HIV Prevention
PLOS One

Key factors in the acceptability of treatment as prevention (TasP) in Scotland: a qualitative study with communities affected by HIV
STI